Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 102k | $388k | 323% | Mar 2024 |
|
| Citadel Advisors | 73k | $276k | 397% | Mar 2024 |
|
| Morgan Stanley | 72k | $273k | 63% | Mar 2024 |
|
| Simplex Trading | 18k | $69k | 100% | Mar 2024 |
|
| Geode Capital Management | 10k | $40k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 10k | $38k | 0% | Mar 2024 |
|
| Group One Trading | 7.2k | $27k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 7.2k | $27k | 2917% | Mar 2024 |
|
| UBS Group | 3.1k | $12k | -16% | Mar 2024 |
|
| Steward Partners Investment Advisory | 3.0k | $11k | 0% | Mar 2024 |
|
| Barclays | 1.0k | $4.0k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 400.00 | $1.5k | 0% | Mar 2024 |
|
| Red Tortoise | 150.00 | $568.995000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 1.00 | $4.000000 | 0% | Mar 2024 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Edmond De Rothschild Holding | Dec 2023 | 13k | $35k |
| Susquehanna International Group | Sep 2023 | 12k | $20k |
| Citigroup | Dec 2023 | 4.7k | $13k |
| Bank of America Corporation | Dec 2023 | 266.00 | $717.987200 |
| Advisory Services Network | Dec 2023 | 43.00 | $116.001100 |